HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kilian Eyerich Selected Research

Kilian Eyerich Research Topics

Disease

31Psoriasis (Pustulosis Palmaris et Plantaris)
01/2024 - 01/2008
24Atopic Dermatitis (Atopic Eczema)
05/2024 - 01/2006
13Inflammation (Inflammations)
01/2024 - 01/2006
11Eczema
05/2024 - 06/2010
9Skin Diseases (Skin Disease)
12/2023 - 11/2010
6Infections
02/2024 - 01/2009
6Hypersensitivity (Allergy)
09/2020 - 01/2008
4Contact Dermatitis (Eczema, Contact)
01/2018 - 01/2008
3Autoimmune Diseases (Autoimmune Disease)
01/2020 - 09/2010
2Erythema
05/2024 - 12/2023
2Edema (Dropsy)
05/2024 - 09/2020
2Psoriatic Arthritis
01/2024 - 10/2022
2Asthma (Bronchial Asthma)
01/2023 - 02/2013
2Kaposi Varicelliform Eruption (Eczema Herpeticum)
01/2023 - 09/2021
2Disease Progression
11/2022 - 10/2022
2Chronic Urticaria
01/2022 - 01/2021
2Pain (Aches)
01/2022 - 01/2022
2Pruritus (Itching)
09/2021 - 01/2021
2Urticaria (Hives)
01/2021 - 01/2020
2Allergic Contact Dermatitis
01/2021 - 01/2010
2Lichen Planus (Lichen Ruber Planus)
07/2020 - 11/2010
2Neoplasms (Cancer)
01/2020 - 11/2012
2Acrodermatitis (Gianotti Crosti Syndrome)
07/2018 - 07/2018
2Dermatitis
01/2018 - 01/2014
2Wounds and Injuries (Trauma)
11/2015 - 02/2013
2Chronic Mucocutaneous Candidiasis
08/2011 - 11/2008
2Candidiasis (Moniliasis)
11/2008 - 12/2007
1Actinomycosis
02/2024
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2024
1Blister (Bulla)
12/2023
1Hyperplasia
12/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2023
1Atherosclerosis
01/2023
1Melanoma (Melanoma, Malignant)
01/2023
1Myocardial Infarction
01/2023
1Necrosis
10/2022
1Type 2 Diabetes Mellitus (MODY)
10/2022

Drug/Important Bio-Agent (IBA)

12Interleukin-17 (Interleukin 17)IBA
10/2022 - 11/2008
11CytokinesIBA
01/2024 - 12/2007
11Biomarkers (Surrogate Marker)IBA
12/2023 - 01/2017
8dupilumabIBA
12/2023 - 11/2019
6Proteins (Proteins, Gene)FDA Link
01/2024 - 12/2009
5InterleukinsIBA
01/2024 - 11/2012
5Interleukin-22 (IL-22)IBA
11/2015 - 11/2008
4Immunoglobulin E (IgE)IBA
01/2023 - 01/2008
4AntigensIBA
01/2021 - 01/2008
4HaptensIBA
01/2018 - 01/2010
3guselkumabIBA
12/2023 - 12/2019
3upadacitinibIBA
12/2023 - 09/2021
3Janus KinasesIBA
12/2023 - 01/2022
3abrocitinibIBA
12/2023 - 01/2022
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2023 - 01/2022
3baricitinibIBA
12/2023 - 01/2022
3secukinumabIBA
01/2023 - 04/2016
3ixekizumabIBA
07/2019 - 07/2018
3NickelIBA
01/2014 - 01/2008
2AutoantibodiesIBA
12/2023 - 01/2022
2ChemokinesIBA
12/2023 - 12/2009
2Matrix Metalloproteinases (MMPs)IBA
12/2023 - 01/2023
2Interleukin-13IBA
12/2023 - 10/2022
2Interleukin-23 (Interleukin 23)IBA
12/2023 - 01/2021
2HLA-C Antigens (HLA-C)IBA
10/2022 - 10/2022
2Ustekinumab (CNTO 1275)FDA Link
10/2022 - 01/2018
2risankizumabIBA
10/2022 - 10/2022
2Omalizumab (Xolair)FDA Link
01/2022 - 01/2021
2AllergensIBA
01/2019 - 01/2009
2Toll-Like Receptor 7IBA
01/2018 - 10/2017
2Interleukin-10 (Interleukin 10)IBA
07/2014 - 12/2007
1lebrikizumabIBA
05/2024
1Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link
02/2024
1Anti-Bacterial Agents (Antibiotics)IBA
02/2024
1LipidsIBA
01/2024
1Interleukin-12 (IL 12)IBA
01/2024
1Immunomodulating AgentsIBA
01/2024
1FumaratesIBA
12/2023
1Keratin-16 (Keratin 16)IBA
12/2023
1LigandsIBA
12/2023
1Calcium-Binding ProteinsIBA
12/2023
1S100A12 ProteinIBA
12/2023
1Phosphodiesterase 4 InhibitorsIBA
12/2023
1bimekizumabIBA
01/2023
1RNA (Ribonucleic Acid)IBA
01/2023
1EnzymesIBA
01/2023
1Formaldehyde (Formol)FDA Link
01/2023
1Immunologic Factors (Immunomodulators)IBA
01/2023
1ParaffinIBA
01/2023
1Janus Kinase InhibitorsIBA
01/2023
1HLA-B Antigens (HLA-B)IBA
10/2022
1Kallikreins (Kallikrein)IBA
10/2022
1TyramineIBA
10/2022
1Macrophage Colony-Stimulating FactorIBA
10/2022
1galactaric acid (mucic acid)IBA
10/2022
1Carrier Proteins (Binding Protein)IBA
10/2022
1IntegrinsIBA
10/2022
1Interleukin-23 Subunit p19IBA
10/2022
1LipopolysaccharidesIBA
10/2022
1Immunoglobulin G (IgG)IBA
10/2022

Therapy/Procedure

17Therapeutics
02/2024 - 01/2008
4Precision Medicine
06/2023 - 02/2015
2Immunotherapy
11/2020 - 10/2018